Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

Cell reports - 21 Feb 2013

Ogembo Javier G, Kannan Lakshmi, Ghiran Ionita, Nicholson-Weller Anne, Finberg Robert W, Tsokos George C, Fingeroth Joyce D

Abstract excerpt

Epstein-Barr virus (EBV) attachment to primary B cells initiates virus entry. Although CD21 is the only known receptor for EBVgp350/220, a recent report documents EBV-infected B cells from a patient genetically deficient in CD21. On normal resting B cells, CD21 forms two membrane complexes: one with CD19 and another with CD35. Whereas the CD21/CD19 complex is widely retained on immortalized and B cell tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD19
Share to K562 Cells
Share to Precursor Cells, B-Lymphoid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Receptors, Complement 3b

Share to Receptors, Complement 3d

Share to Viral Matrix Proteins

Share to Virus Attachment

Share to Virus Internalization

Source

Open in PubMed Open full text

Identifiers

PMID: 23416052
DOI: 10.1016/j.celrep.2013.01.023
PMCID: PMC3633082

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.PMID 23416052Read ↗

Isolating the Epstein-Barr Virus gp350/220 Binding Site on Complement Receptor Type 2 (CR2/CD21)Semantic proximity Read ↗

B cell activation leads to shedding of complement receptor type II (CR2/CD21)Semantic proximity Read ↗

Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralizationSemantic proximity Read ↗

The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d bindingSemantic proximity Read ↗

Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350Semantic proximity Read ↗

Molecular Basis of the Interaction between Complement Receptor Type 2 (CR2/CD21) and Epstein-Barr Virus Glycoprotein gp350Semantic proximity Read ↗

Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.Semantic proximity Read ↗

Cutting Edge: Epstein-Barr Virus Transactivates the HERV-K18 Superantigen by Docking to the Human Complement Receptor 2 (CD21) on Primary B CellsSemantic proximity Read ↗

Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a CoreceptorSemantic proximity Read ↗

Epstein-Barr Virus Binding to CD21 Activates the Initial Viral Promoter via NF-κB InductionSemantic proximity Read ↗

A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.Semantic proximity Read ↗

Uncoupling CD21 and CD19 of the B-cell coreceptor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.